Most cited papers from Sanifit (Spain)

Sanifit (Spain)

What are the most cited papers from Sanifit (Spain)?

The most cited paper from Sanifit (Spain) is "Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis" (Paolo Raggi, Antonio Bellasi, David A. Bushinsky et al., 2019), with 154 citations. Next come "Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification" (52) and "Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis" (50).

Published FieldAccess

Showing 35 of 35 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis Paolo Raggi, Antonio Bellasi, David A. Bushinsky et al. · Circulation Open access	11 Nov 2019	154
2	Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification Miguel D. Ferrer, Markus Ketteler, Fernando Tur et al. · PLoS ONE Open access	9 May 2018	52
3	Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis Vincent Mathias Brandenburg, Smeeta Sinha, José‐Vicente Torregrosa et al. · Journal of Nephrology	10 Aug 2019	50
4	Inositol Hexakisphosphate Inhibits Osteoclastogenesis on RAW 264.7 Cells and Human Primary Osteoclasts María del Mar Arriero, Joana Maria Ramis, Joan Perelló et al. · PLoS ONE Open access	14 Aug 2012	50
5	Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis Joan Perelló, Miguel D. Ferrer, María del Mar Pérez Gómez et al. · British Journal of Pharmacology Open access	19 Jun 2020	48
6	Direct Covalent Grafting of Phytate to Titanium Surfaces through Ti–O–P Bonding Shows Bone Stimulating Surface Properties and Decreased Bacterial Adhesion Alba Córdoba, Margarita Hierro‐Oliva, Miguel A. Pacha‐Olivenza et al. · ACS Applied Materials & Interfaces Open access	18 Apr 2016	44
7	A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma Miguel D. Ferrer, María Mar Pérez, M. M. Cànaves et al. · Scientific Reports Open access	25 Jul 2017	40
8	Plant phosphates, phytate and pathological calcifications in chronic kidney disease Juan Manuel Buades, Pilar Sanchís, Joan Perelló Bestard et al. · Nefrología (English Edition) Open access	2017	40
9	First‐time‐in‐human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification Joan Perelló, Pieter Joubert, Miguel D. Ferrer et al. · British Journal of Clinical Pharmacology Open access	3 Oct 2018	38
10	The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis Smeeta Sinha, Lisa J. Gould, Sagar U. Nigwekar et al. · Clinical Kidney Journal Open access	2 Jul 2021	37
11	Fosfatos de origen vegetal, fitato y calcificaciones patológicas en la enfermedad renal crónica Juan Manuel Buades, Pilar Sanchís Cortés, Joan Perelló Bestard et al. · Nefrología Open access	6 Oct 2016	37
12	Validation of an LC–MS bioanalytical method for quantification of phytate levels in rat, dog and human plasma Fernando Tur, Eva Tur, Irene Lenthéric et al. · Journal of Chromatography B	8 Apr 2013	34
13	SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels Joan Perelló, Miquel Gómez, Miguel D. Ferrer et al. · Journal of Nephrology Open access	19 Jan 2018	32
14	Differential Response of MC3T3-E1 and Human Mesenchymal Stem Cells to Inositol Hexakisphosphate María del Mar Arriero, Joana Maria Ramis, Joan Perelló et al. · Cellular Physiology and Biochemistry Open access	2012	32
15	Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An Overview Maria Bogdanova, Arsenii Zabirnyk, Anna Malashicheva et al. · Frontiers in Pharmacology Open access	2 Jun 2022	27
16	Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis David A. Bushinsky, Paolo Raggi, Jordi Bover et al. · Clinical Journal of the American Society of Nephrology Open access	7 Apr 2021	22
17	A Novel Ex Vivo Model of Aortic Valve Calcification. A Preliminary Report Arsenii Zabirnyk, María del Mar Pérez Gómez, Marc Blasco et al. · Frontiers in Pharmacology Open access	17 Dec 2020	22
18	SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification Arsenii Zabirnyk, Miguel D. Ferrer, Maria Bogdanova et al. · Vascular Pharmacology Open access	19 Aug 2019	21
19	Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial Paolo Raggi, Antonio Bellasi, Smeeta Sinha et al. · Kidney International Reports Open access	4 Nov 2020	18
20	Hypothesis: Phytate is an important unrecognised nutrient and potential intravenous drug for preventing vascular calcification Pieter Joubert, Markus Ketteler, Carolina Salcedo et al. · Medical Hypotheses	14 Jul 2016	18
21	A phase 1b randomized, placebo‐controlled clinical trial with SNF472 in haemodialysis patients Carolina Salcedo, Pieter Joubert, Miguel D. Ferrer et al. · British Journal of Clinical Pharmacology Open access	11 Jan 2019	16
22	Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification Antonio Bellasi, Paolo Raggi, Jordi Bover et al. · Clinical Kidney Journal Open access	28 Sep 2019	12
23	Phytate levels in biological fluids of mammals Joan Perelló, Felix Grases · Journal of Chromatography B	3 Jan 2014	9
24	A novel assay to measure calcification propensity: from laboratory to humans María Mar Pérez, Miguel D. Ferrer, Marta Lazo-Rodríguez et al. · Scientific Reports Open access	16 Oct 2020	8
25	P1234SNF472 IMPROVES LIMB BLOOD PERFUSION AND WALKING ABILITY IN A PERIPHERAL ARTERY DISEASE VASCULAR CALCIFICATION RAT MODEL Firas Bassissi, Miguel David Ferrer Reynes, María Mar Pérez et al. · Nephrology Dialysis Transplantation	Jun 2020	2
26	Mechanistic insights into protonation state as a critical factor in hFPPS enzyme inhibition David Fernández, Joaquín Ortega‐Castro, Laura Mariño et al. · Journal of Computer-Aided Molecular Design	16 Jun 2015	2
27	Hexasodium Fytate (SNF472 or CSL525) Inhibits Ectopic Calcification in Various Pseudoxanthoma Elasticum and Calcinosis Cutis Animal Models Miguel D. Ferrer, Maria del Mar Pérez-Ferrer, Marc Blasco et al. · Pharmaceuticals Open access	14 Apr 2025	1
28	Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification Joan Perelló, Joan J. Alberti, Juan Vicente Torres et al. · Frontiers in Pharmacology Open access	7 Feb 2024	0
29	FC 107SNF472 ATTENUATES THE PROGRESSION OF FEMORAL ARTERY CALCIFICATION AND RECOVERS LIMB BLOOD PERFUSION AND WALKING ABILITY IN A RAT MODEL OF PERIPHERAL ARTERY DISEASE Firas Bassissi, Miguel David Ferrer Reynes, María Mar Pérez et al. · Nephrology Dialysis Transplantation	May 2021	0
30	SO086SNF472 CONSISTENTLY SLOWS PROGRESSION OF CORONARY CALCIFICATION IN PATIENTS ON HEMODIALYSIS: SUBGROUP ANALYSIS OF THE CALIPSO STUDY Paolo Raggi, Antonio Bellasi, David A. Bushinsky et al. · Nephrology Dialysis Transplantation Open access	Jun 2020	0
31	P0884MYO-INOSITOL HEXAPHOSPHATE PEGYLATION IMPROVES BIOAVAILABILITY BUT REDUCES ITS ANTI-VASCULAR CALCIFICATION EFFECT IN RATS María Mar Pérez, Miguel David Ferrer Reynes, Joaquín Ortega‐Castro et al. · Nephrology Dialysis Transplantation	Jun 2020	0
32	P4487Inhibition of aortic valve calcification by SNF472 in vitro Arsenii Zabirnyk, Maria Bogdanova, Miguel D. Ferrer et al. · European Heart Journal	Oct 2019	0
33	FP446IN VITRO EFFECTS OF SNF472 ON OSTEOBLAST CELL CULTURE Geert J. S. Behets, Miguel D. Ferrer, María Mar Pérez et al. · Nephrology Dialysis Transplantation Open access	Jun 2019	0
34	FP633A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE 2B STUDY TO ASSESS THE EFFECT OF SNF472 ADDED TO STANDARD OF CARE ON PROGRESSION OF CARDIOVASCULAR CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE HAEMODIALYSIS (CaLIPSO STUDY) Paolo Raggi, Antonio Bellasi, Jordi Bover Sanjuán et al. · Nephrology Dialysis Transplantation	Jun 2019	0
35	SP655DESIGN OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SNF472 FOR THE TREATMENT OF CALCIFIC UREMIC ARTERIOLOPATHY (CALCIPHYLAXIS) Smeeta Sinha, Glenn Matthew Chertow, Vincent Mathias Brandenburg et al. · Nephrology Dialysis Transplantation	Jun 2019	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.